Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide at 39 Weeks Follow up
Status:
Completed
Trial end date:
2018-07-30
Target enrollment:
Participant gender:
Summary
The objective of this sub-study is to evaluate the efficacy and safety at 39 week follow up
of a single injection of Cingal for relief of joint pain in subjects with OA of the knee who
have not responded to conservative treatment (weight reduction, physical therapy, pain
medications, etc.).